Industrial Nanotech, Inc., an emerging global leader in nanotechnology based energy saving solutions, today announced that the Company’s patented thermal insulation and protective coatings are now being used as an OEM (original equipment manufacturer) upgrade application on new textile machinery.
BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, announced today that it has entered into an amendment of its existing credit facility from Hercules Technology III, L.P., an affiliate of Hercules Technology Growth Capital. Under the amendment, the company borrowed an additional $15 million in growth capital, less the repayment of the outstanding balance on BIND’s existing term loan facility of approximately $3 million.
TechNavio, a tech-focused research firm, has published a new report on the Global Carbon Nanotubes (CNTs) Market, which is expected to grow at a CAGR of 14.84 percent from 2014-2019.
Scott Rickert, Chairman and CEO of PEN Inc., was recently asked to share his experience in nanotechnology commercialization in a webinar entitled "Roadblocks to Success in Nanotechnology Commercialization -- What Keeps the Small and Medium Enterprise Community Up at Night?" The online event was sponsored by The National Nanotechnology Coordination Office (NNCO), on behalf of the Nanoscale Science, Engineering, and Technology (NSET) Subcommittee of the Committee on Technology, National Science and Technology Council (NTSC), under the White House Office of Science and Technology Policy.
DNA Electronics Ltd (‘DNAe’), the inventors of semiconductor DNA sequencing technology and developers of a new, revolutionary point-of-need test for blood infections, has on 15 January 2015 completed the acquisition of the entire issued share capital of nanoMR Inc. (‘nanoMR’), an Albuquerque based developer of a novel system for rapid isolation of rare cells in the bloodstream for a total cash consideration of approximately $24 million by way of a merger under the laws of Delaware, USA.
This BCC Research study focuses on nanomaterials that are used in printing, printing techniques, such as nanolithography and inkjet printing, and key applications that benefit from nanotechnology enabled printing. Market potential is provided for the next five years.
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, and OnCore Biopharma, Inc., a biopharmaceutical company dedicated to discovering, developing and commercializing an all-oral cure for patients suffering from chronic hepatitis B virus (HBV) infection, announced today that they have agreed to merge to create a new leading global HBV company focused on developing a curative regimen for hepatitis B patients by combining multiple therapeutic approaches.
Carbon Sciences Inc., focused on the development of a breakthrough technology to mass-produce graphene, the new miracle material, today announced that the company and Dr. Kaustav Banerjee have jointly launched Transphene, Inc., a new graphene venture.
NanoViricides, Inc., has completed the purchase of the state of the art cGMP-compliant Manufacturing and R&D facility located in Shelton, Connecticut, from Inno-Haven, LLC.
Research and Markets has announced the addition of the "Global Nanoparticle Market Outlook 2020" report to their offering.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.